Study highlights importance of expanding genetic testing for breast cancer patients

[News]

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, working in collaboration with researchers from the Harvard Medical School, today announced that the Journal of...

More... (http://www.medicalnewstoday.com/releases/308572.php)